Bruker Announces Virtual Meeting Option for the Company’s 2020 Annual Stockholders Meeting
May 11 2020 - 8:00AM
Business Wire
Bruker Corporation (Nasdaq: BRKR) today announced that it is
adding a virtual meeting option to its 2020 Annual Meeting of
Stockholders as a result of continuing concerns surrounding the
COVID-19 pandemic. The Annual Meeting will be held on Thursday, May
21, 2020 at 10:00 a.m., Eastern Time, at the offices of Morgan,
Lewis & Bockius LLP, One Federal Street, Boston, Massachusetts
02110. However, stockholders are strongly encouraged to avail
themselves of the virtual meeting option rather than attending in
person.
As described in Bruker’s proxy materials relating to the Annual
Meeting, which were filed with the Securities and Exchange
Commission on April 22, 2020, stockholders of record at the close
of business on March 23, 2020 are entitled to vote at the Annual
Meeting. Stockholders who wish to attend the Annual Meeting
virtually must register at http://viewproxy.com/brukercorp/2020 by
11:59 p.m., Eastern Time, on May 18, 2020. Please refer to the 2020
Annual Meeting FAQs included in the “Virtual Meeting Registration”
tab for further registration instructions and technical
support.
Any stockholder who attends the Annual Meeting in person will be
required to wear a mask or cloth face covering in accordance with
state and local orders and guidance, and will be subject to
additional screening requirements, including responding to
questions about COVID-19 symptoms and an infrared thermometer
check.
Bruker encourages eligible stockholders to vote on the proposals
prior to the Annual Meeting using the instructions provided in the
proxy statement previously distributed. The proxy card included
with the proxy materials previously distributed may continue to be
used to vote shares in connection with the Annual Meeting.
Stockholders will also have the opportunity to vote their shares
during the Annual Meeting either in person or via the instructions
provided in the Virtual Meeting Registration.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high-performance scientific instruments and
high-value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular research, in applied and pharma applications, in
microscopy and nanoanalysis, and in industrial applications, as
well as in cell biology, preclinical imaging, clinical phenomics
and proteomics research and clinical microbiology. For more
information, please visit: www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200511005290/en/
Miroslava Minkova Director, Investor Relations & Corporate
Development Bruker Corporation T: +1 (978) 663 – 3660, ext. 1479 E:
Miroslava.Minkova@Bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Apr 2023 to Apr 2024